Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
196-210 of 437
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Project Oncology®Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
John Cho, MD, PhD, FRCPC
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Project Oncology®From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Ryan Quigley
Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Project Oncology®Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Project Oncology®Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Project Oncology®Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
- advertisement
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Charles Turck, PharmD, BCPS, BCCCP
Evandro Bezerra, MD
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Ryan Quigley
Hallie Blevins, PhD
Marlene Mimi Maeusli, PhD.
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Balazs Halmos, MD, MS
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Balazs Halmos, MD, MS
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Project Oncology®Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Kathleen N. Moore, MD
- advertisement
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Project Oncology®Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Kathleen N. Moore, MD
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Project Oncology®Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Kathleen N. Moore, MD
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Project Oncology®Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Marlene Mimi Maeusli, PhD.